A thin search result says Lilly has cut the price of its weight loss drug. No figures, dates or product names are included.
Recap by typeshit. Full story at Meteo.gr.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Dr. Madz Abraham went on NET 25 with host Kada Umaga to talk through the science behind collagen peptides. A skincare angle on the peptide conversation.
He sets semaglutide's 14.9% average weight loss in its main obesity trial against tirzepatide's 20.9% at the top dose.
Loading…